New York State Common Retirement Fund
ODT

New York State Common Retirement Fund’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

New York State Common Retirement Fund’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-135
Closed – – 3623
2021
Q2 		$0 Sell
135
-12,265
-99% -$42.1K ﹤0.01% 3596
2021
Q1 		$42K Hold
12,400
– – ﹤0.01% 3242
2020
Q4 		$238K Hold
12,400
– – ﹤0.01% 2684
2020
Q3 		$167K Hold
12,400
– – ﹤0.01% 2722
2020
Q2 		$525K Buy
12,400
+2,400
+24% +$77.7K ﹤0.01% 2175
2020
Q1 		$276K Hold
10,000
– – ﹤0.01% 2305
2019
Q4 		$325K Buy
10,000
+1,200
+14% +$37.2K ﹤0.01% 2504
2019
Q3 		$229K Hold
8,800
– – ﹤0.01% 2699
2019
Q2 		$323K Hold
8,800
– – ﹤0.01% 2589
2019
Q1 		$195K Hold
8,800
– – ﹤0.01% 2734
2018
Q4 		$124K Hold
8,800
– – ﹤0.01% 2901
2018
Q3 		$171K Hold
8,800
– – ﹤0.01% 2897
2018
Q2 		$194K Buy
8,800
+4,600
+110% +$107K ﹤0.01% 2888
2018
Q1 		$89K Buy
+4,200
New +$99K ﹤0.01% 2968

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund's ODT Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q3 2021, closing a stake of 135 shares.

New York State Common Retirement Fund first reported a position in ODT in Q1 2018 and held it in 14 quarters. The position peaked at $525K in Q2 2020. 58 funds tracked by Wall St. Rank hold ODT as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 135 Odonate Therapeutics, Inc. Common Stock shares in Q3 2021.
  • New York State Common Retirement Fund first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 14 quarters.
  • New York State Common Retirement Fund's Odonate Therapeutics, Inc. Common Stock position peaked at $525K in Q2 2020.
  • 58 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.